Amicogen, Inc. (KOSDAQ:092040)

Amicogen Statistics

Total Valuation

Amicogen has a market cap or net worth of KRW 209.12 billion. The enterprise value is 311.41 billion.

Market Cap	209.12B
Enterprise Value	311.41B

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Amicogen has 54.82 million shares outstanding. The number of shares has increased by 15.62% in one year.

Current Share Class	54.82M
Shares Outstanding	54.82M
Shares Change (YoY)	+15.62%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.94%
Owned by Institutions (%)	4.22%
Float	49.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.78
PB Ratio	1.74
P/TBV Ratio	2.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.27
EV / Sales	2.65
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.41

Financial Position

The company has a current ratio of 0.75, with a Debt / Equity ratio of 0.96.

Current Ratio	0.75
Quick Ratio	0.47
Debt / Equity	0.96
Debt / EBITDA	n/a
Debt / FCF	-2.75
Interest Coverage	-1.28

Financial Efficiency

Return on equity (ROE) is -28.99% and return on invested capital (ROIC) is -2.37%.

Return on Equity (ROE)	-28.99%
Return on Assets (ROA)	-2.01%
Return on Invested Capital (ROIC)	-2.37%
Return on Capital Employed (ROCE)	-6.44%
Revenue Per Employee	498.82M
Profits Per Employee	-210.31M
Employee Count	236
Asset Turnover	0.32
Inventory Turnover	2.91

Taxes

Income Tax	-918.88M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.37% in the last 52 weeks. The beta is 0.61, so Amicogen's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	-14.37%
50-Day Moving Average	3,826.90
200-Day Moving Average	3,759.88
Relative Strength Index (RSI)	48.30
Average Volume (20 Days)	350,404

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Amicogen had revenue of KRW 117.72 billion and -49.63 billion in losses. Loss per share was -902.26.

Revenue	117.72B
Gross Profit	30.06B
Operating Income	-11.96B
Pretax Income	-49.37B
Net Income	-49.63B
EBITDA	-185.11M
EBIT	-11.96B
Loss Per Share	-902.26

Balance Sheet

The company has 23.83 billion in cash and 115.57 billion in debt, giving a net cash position of -91.73 billion or -1,673.45 per share.

Cash & Cash Equivalents	23.83B
Total Debt	115.57B
Net Cash	-91.73B
Net Cash Per Share	-1,673.45
Equity (Book Value)	119.97B
Book Value Per Share	1,996.09
Working Capital	-17.38B

Cash Flow

In the last 12 months, operating cash flow was -28.74 billion and capital expenditures -13.29 billion, giving a free cash flow of -42.03 billion.

Operating Cash Flow	-28.74B
Capital Expenditures	-13.29B
Free Cash Flow	-42.03B
FCF Per Share	-766.70

Margins

Gross margin is 25.54%, with operating and profit margins of -10.16% and -42.16%.

Gross Margin	25.54%
Operating Margin	-10.16%
Pretax Margin	-41.94%
Profit Margin	-42.16%
EBITDA Margin	-0.16%
EBIT Margin	-10.16%
FCF Margin	n/a

Dividends & Yields

Amicogen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.62%
Shareholder Yield	n/a
Earnings Yield	-23.73%
FCF Yield	-20.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 13, 2023. It was a forward split with a ratio of 2.

Last Split Date	Dec 13, 2023
Split Type	Forward
Split Ratio	2

Scores

Amicogen has an Altman Z-Score of 0.95 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.95
Piotroski F-Score	2